Abstract
purpose. Dietary n-3 polyunsaturated fatty acid deficiency and prematurity are both associated with suboptimal visual function in nonhuman primates and in humans. This study reports measurements of retinal long chain polyunsaturate (LCP) concentrations and electroretinogram (ERG) parameters for term and preterm neonatal baboons consuming clinically relevant diets.
methods. ERGs and retinal fatty acid compositions were obtained from baboon neonates in four groups: term-delivered/breast-fed (B), term/formula-fed (T−), preterm/formula-fed (P−), and preterm/formula (P+) supplemented with long chain polyunsaturates. Initial a-wave slope change (ä), a-wave amplitude (aamp) and implicit time (ai), and b-wave amplitude (bamp) and implicit time (bi) were determined and correlations to retinal fatty acid concentrations were evaluated.
results. The P+ group ä and bamp significantly improved between 0 and 4 weeks’ adjusted age, whereas no P− group parameter improved with age. At four weeks, both aamp and bamp were significantly greater in group B than in all other groups, and ä and ai were greater for P+ than for P−. Concentrations of 22:6n-3, 22:5n-3, and Σn-3 and the 22:5n-6/22:6n-3 ratio correlated positively with improved retinal response parameters, whereas 22:5n-6, 22:4n-6, 20:4n-6, 20:3n-6, 20:2n-9, 20:1n-9, and 18:1n-9 all correlated negatively (P < 0.05); saturates were uncorrelated. The parameters most linearly related to retinal 22:6n-3 were ä, ai, and aamp. Retinal 20:4n-6 concentrations were not influenced by prematurity or supplementation.
conclusions. Breast-feeding optimizes retinal response in 4-week-old baboons. Formula supplemented with 22:6n-3 prevents a decrease in retinal 22:6n-3 and improves preterm ERG parameters compared with unsupplemented formula. Retinal 22:6n-3 status is most closely associated with a-wave parameters.
Retinal docosahexaenoic acid (DHA, or 22:6n-3) concentrations correlates highly with retinal function in rats,
1 and severe n-3 deficiency is associated with low 22:6n-3 and impaired visual performance, as assessed by electroretinography (ERG) in several species
2 3 4 5 and by preferential looking tests
6 in rhesus monkeys. The biochemical n-3 deficiency markers in cerebral cortex and retina, low 22:6n-3 and high 22:5n-6, can be reversed in rhesus monkeys with a few weeks of feeding with fish oil
5 7 ; however, the ERG parameters do not become normal. The mechanism by which 22:6n-3 influences retinal function remains unclear.
8
The preterm human infant is thought to be particularly vulnerable to dietary n-3 deficiency. Preterm infants of less than 800 g birthweight and 30 weeks’ gestational age routinely survive and until recently were fed formulas devoid of long chain polyunsaturates (LCP, 20 or more carbons). Although it has been established that primate fetuses,
9 preterm and term baboon neonates,
10 and preterm human infants
11 12 synthesize 22:6n-3 from 18:3n-3, it is not known whether preterm infants can synthesize sufficient 22:6n-3 to meet the demands of rapid brain and retinal growth.
13 Clinical studies of preterm infants generally agree that supplementation with LCP improves development of the visual system, apparently without risk,
14 though the importance of transitory improvements in visual function of healthy term infants fed LCP-free formulas is controversial.
15
Ideally, studies relating visual function to biochemical composition would measure a functional outcome, a correlate of function, or some behavioral response and then have access to retinal tissue for analysis in the same animal. Such studies have been reported most extensively using electroretinography in guinea pigs
16 17 18 19 ; however, unlike the guinea pig, the primate retina has a high density of cones and a fovea.
20 Thus, the most accurate animal models of human retinal function are restricted to higher primates.
Tissue sampling in human infants is generally constrained by ethical guidelines to the sampling of blood a few times during infancy. Fatty acids in blood-borne pools (for example, plasma or red blood cells) are analyzed and used as biochemical indicators of LCP status, and correlations to functional tests are then drawn (e.g., Refs.
21 22 ). A major drawback of this approach is that conclusions are limited to correlations between indirect measures of tissue fatty acid status and function. The detailed relationship between retinal composition and plasma or red blood cell fatty acid concentrations must therefore be inferred. Rigorous direct comparisons are available for retinal function and tissue fatty acid composition in a limited number of animal models,
18 23 and the application of these results to humans must be approached with caution.
We report an investigation of the influence of prematurity and dietary LCP on retinal function and tissue fatty acid composition in four randomized groups of baboon neonates: two term groups, breast-fed and formula-fed, and two preterm groups, formula-fed with or without LCP. Lactating females in the breastfed group consumed a standard primate diet that included fish meal containing n-3 LCP (22:6n-3, 22:5n-3, and 20:5n-3), and their milk represents an optimal source of n-3 LCP, thus establishing the best possible control group. Comparison of the unsupplemented groups permits evaluation of prematurity per se. Comparison of the preterm groups permits evaluation of dietary LCP on prematurity.
The Cornell Institutional Animal Care and Use Committee approved the animal care protocol, and the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) approved the facility. Sixteen pregnant baboons (Papio cynocephalus) were transported from a colony at the Southwest Foundation for Biomedical Research (San Antonio, TX) to the College of Veterinary Medicine at Cornell University. Complete veterinary examinations were performed on all baboons on arrival. They were housed individually in cages within sight of one or more baboons and a video showing other baboons. Temperature (24°C), humidity (70%), and a 14:10-hour light–dark cycle were maintained in the primate rooms.
Sixteen female–neonate pairs were randomized to one of four experimental groups (n = 4): B, breastfed; T−, term, fed conventional formula free of LCP; P−, preterm, fed conventional formula; P+, preterm, fed an LCP-supplemented formula. Females in the B and T− groups delivered spontaneously. The T− neonates were removed from the female within 24 hours of birth, admitted to a nursery, and bottle-fed a conventional commercially available human infant formula with no LCP (Enfacare; Mead-Johnson, Evansville, IN) throughout the study.
At approximately 152 days of gestation (normal term gestation, 182 days), a course of antenatal betamethasone, 175 mg/kg body weight per day, was administered to P− and P+ females at 48 and 24 hours before cesarean section. At approximately 154 days gestation, P− and P+ neonates were removed by cesarean section, according to procedures used previously.
25 Premature neonates were housed in incubators and provided with intrapulmonary surfactant as clinically necessary. No mechanical ventilation was used. Three P+ neonates received surfactant; no P− neonate needed it. Neither lung nor any other tissue fatty acid composition showed any distinct difference as a result of surfactant administration (data not shown).
P− neonates received the same LCP-free formula as T− neonates. The LCP-free formula Enfacare (Mead-Johnson) contains 47% calories as fat. P+ neonates received the same formula, supplemented with 0.3% energy 22:6n-3 and 0.6% energy 20:4n-6 (arachidonic acid, ARA). The DHA and ARA were supplied as a powdered, encapsulated oil and added directly to the formula powder. Formula and LCP powder were kindly provided by Mead-Johnson Nutritionals.
Breast milk was sampled once from the lactating females immediately after neonate necropsy. Studies have shown that total fatty acid concentration in human breast milk decreases with increasing time postpartum, although the concentrations of 22:6n-3 and 20:4n-6, as a percent of fatty acids, are stable.
26
ERG procedures were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. ERGs were performed on the P− and P+ groups at approximately 28 days of life, corresponding to the postconceptional age of normal term birth. ERGs were performed on all groups at 4 weeks’ corrected age, 3 to 5 days before death, at which time the P− and P+ groups were 7.5 weeks’ birth age. A custom-built, computer-based ERG acquisition system (Windows-based software; Microsoft, Redmond, WA), identical with that used in the electrodiagnostic clinic of the Cornell University veterinary hospital was used for the measurements.
Baboon neonates were held supine in the arms of a caregiver in a quiet darkened room for a minimum of 30 minutes for dark adaptation and mydriasis. Ketamine with/without xylazine was injected intramuscularly at the beginning of the procedure, and isoflurane inhalation anesthesia was used throughout. Subdermal platinum-iridium needle electrodes were placed between the eyes (indifferent) and in an ear flap (ground). A local anesthetic (proparacaine) and a cushioning solution (Murocel; Bausch & Lomb, Tampa, FL) were applied to the cornea before placing the active contact lens electrode (ERG-Jet; LKC Technology, Gaithersburg, MD) on the eye, exposed using a lid speculum.
Each eye was tested separately using 50-ms stimuli from a white-light LED. The highest light intensity used was approximately 1.1 × 10
4 lux, as measured with a spectroradiometer (model S1000; Ocean Optics, Dunedin, FL), using a photopic conversion utility of the control software with the unit (C-Spec; Ocean Optics). ERGs were obtained at 9 or 10 intensity steps, differing by 0.5 log unit, starting with the lowest intensity. The highest intensity was shown to be above the dark-adapted b-wave saturation level.
Figure 1 shows a typical ERG series using this protocol and instrumentation, illustrating responses for the eight highest intensities for this particular series.
For all groups, the eighth highest intensity response was chosen as the standard for measurement of a- and b-wave implicit times and amplitudes. The slopes of the ascending limbs of the a-waves were calculated for the six highest intensity responses, and the increase in these slopes with intensity is reported as the parameter ä. In this procedure, a straight line is drawn from the voltage (defined as 0 V) at the time of the flash to the lowest point (highest response intensity) of the a-wave. The slope for each of the six intensities is calculated and plotted against flash intensity, with the lowest intensity set to 1 and the highest set to 6. The resultant straight line is modeled with a linear regression to yield ä as the calculated slope parameter. Slope ä is therefore the increase in initial response with increasing light intensity, similar to a parameter presented by Breton et al.
27
At 4 weeks’ corrected age, neonates were anesthetized with halothane and killed by exsanguination. Retinas were immediately collected in ice-cold saline, frozen in liquid nitrogen, and stored at −80°C until analysis, less than 6 weeks later.
ERG parameters for the four groups were analyzed by one-way analysis of variance (ANOVA) for measurements taken at 4 weeks’ corrected age. When ANOVA was significant, pair-wise comparisons were performed using the Tukey honest significant difference (HSD) test. ERG parameters were tested for significance by paired t-test for the two measurements of the P− or P+ groups, as indicative of significant improvement over time. Significance was declared at P < 0.05 for all tests.
The Pearson correlation coefficient (r) between retinal fatty acids and ERG parameters was calculated for linear least-squares fits for individual animals (n = 16). The correlation coefficient was considered significant if P < 0.05 and |r| > 0.5.
Table 4 presents a summary of the ERG parameters. For the P− and P+ groups, two measurements, performed at two different ages, are presented: (1) 182 days postconceptional age, corresponding to gestational age of normal term birth; and (2) 4 weeks’ adjusted age, corresponding to the same postpartum age at which ERGs were performed on the T− and B groups. Differences between time points within a group (P− or P+) and between the first time points (P− (1) versus P+ (1)) were performed. Statistical tests between groups were also performed on the values for the 4-week adjusted age-matched P− (2), P+ (2), T−, and B neonates.
There was no significant difference in preterm groups in any parameter at the first time point (P− (1) versus P+ (1)). For the P+ group, ä and bamp improved with age (äP+(2) > äP+(1); bamp,P+(2) > bamp,P+(1); P < 0.05), but there was no statistically significant improvement detected in any parameter in the P− group.
The B group amplitudes (aamp and bamp) were significantly greater than in all other groups, whereas the P− group was significantly lower than all groups in ä and higher in ai. No significant differences were found between groups in bi.
Pair-wise comparisons reveal that ä and a
i were greater in the P+ group than in the P− group at the 4-week time point (P+ (2) versus P− (2), showing improvement due to supplementation. Similarly, the T− group had improved ä and a
i compared with the P− group; the catch-up growth in overall body mass of the P− group compared with the T− and B groups, as shown in
Table 1 , does not extend to normalization of retinal function. There were no significant differences between the P+ group and the T− group.
These data directly support the hypothesis that LCP supplementation affects retinal function in primates through concomitant changes in retinal fatty acid composition. The P− group had significantly poorer retinal function as measured by ä and a
i, than the other groups, including the P+ group. This finding, indicating that LCP supplementation improved retinal function, is consistent with functional data from human studies.
21 28 29 30 Our fatty acid measurements are direct evidence that this compromised function is at least in part related to a lower retinal 22:6n-3 concentration.
5 Previous data show that premature infants can synthesize 22:6n-3 from precursor 18:3n-3,
11 12 31 and more recent data demonstrate that fetal baboons can biosynthesize 22:6n-3.
9 All data collected to date indicate that late-term primate fetuses and human premature infants, on average, are more efficient in 18:3n-3 to 22:6n-3 conversion than older neonates.
9 13 The present data, connecting lower retinal 22:6n-3 concentrations in the P− group with poorer retinal response, are among the first direct data showing that the biosynthetic capability of premature primates is insufficient to support optimal function, at least in the immediate perinatal period.
The complex single-flash ERG results from the temporal superposition of several monophasic electrical responses differing in polarity, time-course, and phase. The descending limb of the a-wave represents almost exclusively photoreceptor cell activity,
32 27 whereas the b-wave is a composite of the responses of bipolar cells and Müller cells.
27 33 The ä parameter is related to the amplification factor derived by Breton et al.,
27 which is a measure of the time-course of activation for the phosphodiesterase cascade in the rod outer segments. We found a significant improvement in ä in the P+ group compared with the P− group. The decrease in this parameter suggests that the initial amplification induced by photon absorption of rhodopsin is reduced in the P− group compared with the others, though no absolute turnover calculations can be made. Our data cannot distinguish whether this is due to less rhodopsin, less efficient photon absorption, or poorer amplification. However, the generally linear relationship between 22:6n-3 concentrations and ä is consistent with a central and limiting role for 22:6n-3 in initial events in photoreceptor cell transduction. In addition,
Table 3 shows that the 22:5n-6/22:6n-3 ratio is greater in the P− group than in the P+ group. Recent biophysical studies demonstrating the preference of rhodopsin for 22:6n-3, along with its pivotal role in signal transduction, suggest that a combination of these factors may be at work.
34 35 36
We also found that a
i was significantly increased in preterm neonates consuming no LCP (P−) compared with the other groups at 4 weeks’ adjusted age. There was also a nonsignificant increase in a
i in the P− group between the first and second measurements. Implicit time of the a-wave normally decreases with maturation
37 and these data are further evidence that the retina of these preterm neonates is developmentally delayed.
The b-wave amplitude correlated positively with 22:6n-3, but the interpretation of these data on a physiological level is not straightforward because of two factors: the complex combination of cells that produce the signal and the coupling between the a- and b-wave responses. Although b
amp increased with 22:6n-3, we cannot from our data determine whether this is due to improved function of the systems measured exclusively by the b-wave or by improved function of the photoreceptors, which would couple more signal into the b-wave system. Because the generation of the a- and b-waves derives from the transductional step, it is expected that changes in ä should be reflected as changes in the amplitudes and implicit times of the complete ERG. The general linear relationship of a
amp to both 22:6n-3 concentration and 22:5n-6/22:6n-3 shown in the bottom right panels of
Figures 2 and 3 are consistent with this expectation. However, inspection of the bottom left panel of
Figure 2 reveals that b
amp in the B group was greater than in the P+ group, even though retinal 22:6n-3 did not significantly increase between these two groups. Further, b
amp only slightly responded to increasing retinal 22:6n-3 in the formula (P−, T−, and P+) groups.
Figure 3 , showing the 22:5n-6/22:6n-3 ratio, confirms these observations. These data are strong evidence that 22:6n-3 per se is not the limiting factor in development of b
amp in formula-fed neonates.
The monounsaturates correlated highly with ERG parameters. The n-7 fatty acids correlated positively with retinal performance, whereas the n-9 fatty acids, including Σn-9, correlated negatively with retinal performance. This observation is surprising, because there are no known or, to our knowledge, proposed functional relationships between the monounsaturates and retinal function, other than the general observation that monounsaturates are always present at considerable concentrations. Most mammalian tissues synthesize both the monounsaturated fatty acid (MUFA) series (n-9 and n-7) de novo, primarily from acetate-malonate by the action of fatty acid synthase and a Δ9-desaturase (e.g., stearoyl CoA desaturases
38 ). In addition, it is usually assumed that the physical properties of n-7 versus n-9 MUFAs are sufficiently similar to render them interchangeable for most in vivo physiological processes, although this assumption may not be warranted. Finally, there are no known biochemical roles for MUFA other than as components of structural lipids, as substrates for energy production, or as carbon sources through acetate. Breast milk had a more than five times greater n-7 concentration than the formulas and had lower n-9 (mostly 18:1n-9). Further research is necessary to determine whether the positional isomers of monounsaturates play a specific role in retinal function and, particularly, in the development of b
amp.
The bi parameter was uncorrelated to all but one fatty acid, 18:3n-6. The greater breadth of the b-wave compared with the a-wave, makes accurate localization of its extreme value more difficult, and thus decreases our ability to detect differences in bi due to experimental treatments.
Development of monkey fovea
39 and retinal vasculature
20 occurs earlier in development than in humans. At 4 weeks of life, the monkey fovea is not yet mature and is not adultlike until 12 weeks, whereas the human fovea is adultlike at approximately 1 year of age and continues to develop until 4 to 5 years. Thus, our results establishing an influence of dietary LCP on function apply to the developing, rather than mature, retina, though the stage of development is somewhat later than in the human. A finding of a significant effect in developmental milestones is important even if, as has been noted in human studies,
21 differential effects of diet are transient.
Tissue and breast milk fatty acid compositions are well-known to be influenced by diet, and the degree of influence depends on the specific fatty acid and tissue. For instance, rat retinal 22:6n-3 is susceptible to manipulation of 18:2n-6 concentration,
40 and it is reasonable to hypothesize that diet may have induced the MUFA correlations in the current study. Inspection of
Table 2 reveals that breast milk of our baboons was many times richer in 16:1n-7 than in the formula groups, whereas the major n-9 fatty acid and most abundant fatty acid in all neonate diets, 18:1n-9, was approximately 30% lower in breast milk compared with formulas. These differences could explain the relatively subtle changes in the corresponding retinal fatty acid, shown in
Table 3 and suggest that the strong correlations with function can be explained as coincident with other factors. Caution is warranted in accepting this hypothesis, because similar arguments about metabolic roles and dietary content apply to saturates, particularly 16:0, and no correlation to retinal function was detected.
This randomized study included a breast-fed group (B), which is not possible for ethical reasons in human studies. The B group, which had the greatest mean 22:6n-3 concentration, had greater a
amp and b
amp than any of the other groups, including the P+ group, in which the mean retinal 22:6n-3 concentration was not significantly lower than in the B group. None of the other treatments achieved the level of retinal function, as measured by ERG parameters, as the B group. The optimal performance found for breast-fed neonates cannot be uniquely ascribed to the fatty acid composition of breast milk alone. Breast milk contains a myriad of immunologic factors including antibodies and cells that are not present in formula.
26 In addition, breast-fed neonates remained with the lactating females for the duration of the study, while formula-fed neonates were separated from maternal contact at birth and hand-fed by humans. The effects of non–fatty-acid milk components, as well as psychosocial aspects of the maternal-neonate pair in breast-feeding cannot be dismissed as irrelevant. However, this study accurately simulated the clinical choice of breast-versus bottle-feeding and in this sense is directly applicable to real-world practice.
In summary, these data are direct evidence that primate retinal response is influenced by retinal fatty acid composition and more specifically by 22:6n-3 concentrations. Retinal 22:6n-3 composition in turn is influenced directly by fatty acid composition of clinically relevant diets, by prematurity, and by breast-feeding. Premature neonates benefited measurably from inclusion of LCP in formula. Two ERG parameters improved between time points in the P+ group, but none improved measurably in the P− group. The parameters ä and ai were improved in the P+ group compared with the P− group, whereas other parameters were not significantly different. These comparisons indicate that there is a delay in retinal development specific to prematurity that is at least partially corrected by LCP supplementation. Finally, the groups investigated are of broad clinical importance, and the results obtained in primates are directly relevant to humans.
Present address: Division of Pediatric Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan;
Foster Biomedical Laboratory, Brandeis University, Waltham, Massachusetts;
Department of Nutritional Sciences, University of California, Berkeley, California; and
New York University Medical Center, New York, New York.
Supported by National Institutes of Health Grant EY10208.
Submitted for publication May 17, 2003; revised June 30, 2003; accepted July 5, 2003.
Disclosure:
G.-Y. Diau, None;
E.R. Loew, None;
V. Wijendran, None;
E. Sarkadi-Nagy, None;
P.W. Nathanielsz, None;
J.T. Brenna, Mead-Johnson Nutritionals (C, F, R)
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: J. Thomas Brenna, Division of Nutritional Sciences, Cornell University, Savage Hall, Ithaca, NY 14853;
jtb4@cornell.edu.
Table 1. Characteristics of Baboon Neonates
Table 1. Characteristics of Baboon Neonates
| P− | P+ | T− | B |
| Gender (n = 4 per group) | 3F, 1M | 2F, 2M | 4F | 2F, 2M |
| Conceptional age at delivery (d) | 155.8 ± 1.0 | 153.3 ± 2.4 | 180.2 ± 8.2 | 174.8 ± 11.5 |
| Conceptional age at death (d) | 206.3 ± 4.6 | 205.5 ± 7.3 | 213.5 ± 7.0 | 209.5 ± 11.1 |
| Birth weight (g) | 617.0 ± 58.3 | 624.8 ± 69.1 | 819.8 ± 66.7 | 780.4 ± 121.0 |
| Body weight at death (g)* | 1023.8 ± 179.0 | 1084.5 ± 221.4 | 1168.8 ± 153.1 | 1026.7 ± 147.5 |
| Weight gain (g)* | 406.8 ± 125.9 | 459.8 ± 168.8 | 349.0 ± 131.3 | 246.3 ± 150.9 |
Table 2. Fatty Acid Compositions of Various Diets
Table 2. Fatty Acid Compositions of Various Diets
| Fatty Acid | T− and P− | P+ | B | Mother’s Diet |
| ΣSFA | 30.22 ± 2.66 | 32.36 ± 0.23 | 27.87 ± 8.49 | 30.37 ± 0.66 |
| 14:1 | 0.44 ± 0.02 | 0.55 ± 0.10 | 0.68 ± 0.23 | 1.44 ± 1.06 |
| 16:1n-7 | 1.14 ± 1.38 | 0.26 ± 0.04 | 5.92 ± 2.81 | 16.13 ± 2.64 |
| 18:1n-9 | 42.90 ± 0.79 | 41.95 ± 0.59 | 31.89 ± 5.86 | 17.33 ± 2.69 |
| 20:1n-9 | 0.24 ± 0.01 | 0.26 ± 0.10 | 0.46 ± 0.09 | 0.37 ± 0.03 |
| 18:2n-6 | 22.35 ± 0.42 | 20.11 ± 0.14 | 27.23 ± 3.99 | 27.93 ± 1.36 |
| 18:3n-6 | 0.38 ± 0.04 | 0.18 ± 0.04 | 0.27 ± 0.09 | 0.28 ± 0.07 |
| 20:2n-6 | ND | 0.08 ± 0.11 | 0.78 ± 0.14 | 0.25 ± 0.16 |
| 20:3n-6 | ND | 0.19 ± 0.06 | 0.42 ± 0.11 | 1.31 ± 0.06 |
| 20:4n-6 | ND | 1.21 ± 0.09 | 0.62 ± 0.12 | 0.24 ± 0.04 |
| 22:4n-6 | ND | ND | 0.22 ± 0.06 | ND |
| 18:3n-3 | 2.33 ± 0.02 | 2.06 ± 0.05 | 2.12 ± 0.53 | 2.58 ± 0.22 |
| 20:5n-3 | ND | 0.12 ± 0.02 | 0.34 ± 0.13 | 0.85 ± 0.11 |
| 22:5n-3 | ND | 0.06 ± 0.09 | 0.51 ± 0.15 | 0.20 ± 0.03 |
| 22:6n-3 | ND | 0.61 ± 0.03 | 0.68 ± 0.22 | 0.73 ± 0.03 |
| 18:2n-6/18:3n-3 | 9.6 | 9.8 | 12.8 | 10.8 |
| Σn-6 | 22.77 ± 0.44 | 21.77 ± 0.22 | 29.54 ± 4.23 | 30.01 ± 1.58 |
| Σn-3 | 2.33 ± 0.02 | 2.85 ± 0.17 | 3.65 ± 0.88 | 4.36 ± 0.33 |
| Σn-6/Σn-3 | 9.8 ± 0.5 | 7.6 ± 0.3 | 8.1 ± 4.9 | 6.9 ± 1.8 |
Table 3. Retinal Fatty Acid Compositions
Table 3. Retinal Fatty Acid Compositions
| Fatty Acid | P− | P+ | T− | B |
| 14:0 | 2.89 ± 1.06 | 2.70 ± 1.22 | 2.51 ± 0.85 | 1.83 ± 0.64 |
| 16:0 | 19.9 ± 0.71 | 19.96 ± 0.89 | 20.48 ± 0.85 | 21.82 ± 1.36 |
| 18:0 | 21.82 ± 0.55 | 21.55 ± 1.72 | 21.99 ± 0.46 | 20.75 ± 2.41 |
| 20:0 | 0.27 ± 0.03 | 0.28 ± 0.03 | 0.31 ± 0.05 | 0.30 ± 0.05 |
| 16:1n-9 | 0.93 ± 0.14 | 0.88 ± 0.09 | 0.83 ± 0.04 | 0.98 ± 0.49 |
| 18:1n-9 | 12.81 ± 0.19a | 12.49 ± 0.31a | 12.85 ± 0.45a | 10.75 ± 0.67b |
| 20:1n-9 | 0.89 ± 0.14a | 0.90 ± 0.13a | 0.81 ± 0.05ab | 0.59 ± 0.08b |
| 20:2n-9 | 0.72 ± 0.01a | 0.68 ± 0.04ab | 0.65 ± 0.10ab | 0.53 ± 0.06b |
| 16:1n-7 | 0.33 ± 0.05a | 0.35 ± 0.03a | 0.38 ± 0.050a | 0.57 ± 0.09b |
| 18:1n-7 | 3.14 ± 0.08ab | 2.93 ± 0.11a | 3.56 ± 0.30bc | 3.96 ± 0.40c |
| 18:2n-6 | 3.16 ± 0.33 | 2.63 ± 0.22 | 3.01 ± 0.38 | 3.17 ± 0.56 |
| 18:3n-6 | 0.34 ± 0.05 | 0.34 ± 0.03 | 0.36 ± 0.06 | 0.40 ± 0.07 |
| 20:3n-6 | 2.55 ± 0.28a | 2.03 ± 0.04b | 2.44 ± 0.05a | 2.07 ± 0.17b |
| 20:4n-6 | 10.24 ± 0.41 | 10.07 ± 0.33 | 9.85 ± 0.11 | 9.45 ± 0.57 |
| 22:4n-6 | 2.57 ± 0.20a | 2.08 ± 0.18bc | 2.22 ± 0.20ab | 1.69 ± 0.24c |
| 22:5n-6 | 2.32 ± 0.53a | 1.11 ± 0.27bc | 1.56 ± 0.34b | 0.81 ± 0.20c |
| 22:5n-3 | 0.74 ± 0.04a | 0.60 ± 0.09a | 0.72 ± 0.14a | 1.24 ± 0.31b |
| 22:6n-3 | 14.4 ± 0.55a | 18.44 ± 1.20b | 15.46 ± 1.09a | 19.07 ± 1.41b |
| ΣSFA | 44.88 ± 0.70 | 44.48 ± 0.44 | 45.3 ± 0.80 | 44.71 ± 1.86 |
| ΣMUFA | 18.09 ± 0.35 | 17.55 ± 0.52 | 18.43 ± 0.72 | 16.85 ± 1.15 |
| Σn-9 | 15.35 ± 0.37a | 14.96 ± 0.40a | 15.14 ± 0.51a | 12.86 ± 0.86b |
| Σn-7 | 3.47 ± 0.09ab | 3.27 ± 0.11a | 3.94 ± 0.34b | 4.53 ± 0.36c |
| Σn-6 | 21.18 ± 0.93a | 18.25 ± 0.51bc | 19.44 ± 0.60b | 17.6 ± 0.89c |
| Σn-3 | 15.13 ± 0.58a | 19.03 ± 1.25b | 16.19 ± 1.15a | 20.31 ± 1.68b |
| Σn-6/Σn-3 | 1.40 ± 0.11a | 0.96 ± 0.09bc | 1.21 ± 0.11a | 0.87 ± 0.09c |
| 22:5n-6/22:6n-3 | 0.16 ± 0.04a | 0.06 ± 0.02bc | 0.10 ± 0.02b | 0.04 ± 0.01c |
Table 4. ERG Parameters: ä, Implicit Times (ms), and Amplitudes (μV), expressed as Mean ± SD
Table 4. ERG Parameters: ä, Implicit Times (ms), and Amplitudes (μV), expressed as Mean ± SD
| P−(1)* | P−(2), † | P+(1)* | P+(2), † | T− | B |
| ä | 0.47 ± 0.05 | 0.55 ± 0.27a | 0.40 ± 0.19 | 0.72 ± 0.26b, , ‡ | 0.80 ± 0.36b | 1.12 ± 0.12b |
| a-Wave implicit time (ms) | 25.5 ± 2.4 | 27.3 ± 3.8a | 24.8 ± 1.9 | 23.0 ± 1.8b | 22.5 ± 3.3b | 20.3 ± 1.0b |
| b-Wave implicit time (ms) | 63.0 ± 9.4 | 58.0 ± 7.9 | 66.0 ± 9.9 | 53.8 ± 5.1 | 51.3 ± 1.3 | 53.5 ± 10.3 |
| a-Wave amplitude (μV) | 45.3 ± 19.5 | 32.6 ± 19.5a | 37.8 ± 15.4 | 44.2 ± 15.4a | 45.9 ± 12.2a | 97.7 ± 12.3b |
| b-Wave amplitude (μV) | 90.8 ± 35.1 | 80.3 ± 26.0a | 68.6 ± 45.2 | 105.2 ± 39.9a, , ‡ | 74.4 ± 19.2a | 224.48 ± 63.3b |
Table 5. Pearson’s Correlation Coefficient between Retinal Fatty Acids and ERG Parameters at 4 Weeks’ Adjusted Age
Table 5. Pearson’s Correlation Coefficient between Retinal Fatty Acids and ERG Parameters at 4 Weeks’ Adjusted Age
| Fatty Acids | ä | a-Wave Amplitude | a-Wave Implicit Time | b-Wave Amplitude |
| 16:1n-7 | 0.62 | 0.80, † | — | 0.73, † |
| 18:1n-7 | 0.65 | 0.65 | — | 0.54 |
| 18:3n-6 | — | 0.53 | — | — |
| 18:1n-9 | −0.50 | −0.79, † | 0.54 | −0.74, † |
| 20:1n-9 | −0.59 | −0.72, † | 0.67, † | −0.65 |
| 20:2n-9 | −0.78, † | −0.73, † | 0.79, † | −0.55, † |
| 20:3n-6 | — | — | 0.56 | — |
| 20:4n-6 | — | −0.54 | — | −0.56 |
| 22:4n-6 | −0.56 | −0.71, † | 0.57 | −0.63 |
| 22:5n-6 | −0.51 | −0.61 | — | −0.57 |
| 22:5n-3 | — | 0.63 | — | 0.56 |
| 22:6n-3 | (0.48)* | 0.63 | −0.63 | 0.62 |
| Σn-9 | −0.52 | −0.78, † | 0.62 | −0.71, † |
| Σn-7 | 0.68, † | 0.72, † | — | 0.61 |
| Σn-6 | −0.52 | −0.61 | 0.64, † | −0.57 |
| Σn-3 | 0.50 | 0.67, † | −0.63 | 0.65 |
| Σn-6/Σn-3 | −0.53 | −0.65, † | 0.67, † | −0.62 |
| 22:5n-6/22:6n-3 | −0.52 | −0.62 | 0.54 | −0.58 |
The authors thank Darlene Campbell for technical assistance and Carolyn Tschanz for capable assistance with the manuscript.
Benolken, RM, Anderson, RE, Wheeler, TG. (1973) Membrane fatty acids associated with the electrical response in visual excitation Science 182,1253-1254
[CrossRef] [PubMed]Pawlosky, RJ, Bacher, J, Salem, N, Jr (2001) Ethanol consumption alters electroretinograms and depletes neural tissues of docosahexaenoic acid in rhesus monkeys: nutritional consequences of a low n-3 fatty acid diet Alcohol Clin Exp Res 25,1758-1765
[CrossRef] [PubMed]Igarashi, J, Shimizu, T, Oguchi, S, et al (2002) Retinal neurodevelopmental assessment with electroretinogram in patients with biliary atresia Pediatr Int 44,141-144
[CrossRef] [PubMed]Hoffman, DR, Birch, DG. (1995) Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa Invest Ophthalmol Vis Sci 36,1009-1018
[PubMed]Neuringer, M, Connor, WE, Lin, DS, et al (1986) Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys Proc Natl Acad Sci USA 83,4021-4025
[CrossRef] [PubMed]Neuringer, M, Connor, WE, Van Petten, C, Barstad, L. (1984) Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys J Clin Invest 73,272-276
[CrossRef] [PubMed]Connor, WE, Neuringer, M, Lin, DS. (1990) Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys J Lipid Res 31,237-247
[PubMed]Jeffrey, BG, Weisingerb, HS, Neuringer, M, Mitcheli, DC. (2001) The role of docosahexaenoic acid in retinal function Lipids 36,859-871
[CrossRef] [PubMed]Su, HM, Huang, MC, Saad, NM, et al (2001) Fetal baboons convert 18:3n-3 to 22:6n-3 in vivo: a stable isotope tracer study J Lipid Res 42,581-586
[PubMed]Brenna, JT. (2002) Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man Curr Opin Clin Nutr Metab Care 5,127-132
[CrossRef] [PubMed]Salem, N, Jr, Wegher, B, Mena, P, Uauy, R. (1996) Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants Proc Natl Acad Sci USA 93,49-54
[CrossRef] [PubMed]Carnielli, VP, Wattimena, DJ, Luijendijk, IH, et al (1996) The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids Pediatr Res 40,169-174
[CrossRef] [PubMed]Uauy, R, Mena, P, Wegher, B, et al (2000) Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth Pediatr Res 47,127-135
[CrossRef] [PubMed]Uauy, R, Hoffman, DR. (2000) Essential fat requirements of preterm infants Am J Clin Nutr 71,245S-250S
[PubMed]Auestad, N, Halter, R, Hall, RT, et al (2001) Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study Pediatrics 108,372-381
[CrossRef] [PubMed]Bui, BV, Sinclair, AJ, Vingrys, AJ. (1998) Electroretinograms of albino and pigmented guinea-pigs (Cavia porcellus) Aust NZ J Ophthalmol 26(suppl 1),S98-S100
[CrossRef] Weisinger, HS, Vingrys, AJ, Bui, BV, Sinclair, AJ. (1999) Effects of dietary n-3 fatty acid deficiency and repletion in the guinea pig retina Invest Ophthalmol Vis Sci 40,327-338
[PubMed]Weisinger, HS, Vingrys, AJ, Sinclair, AJ. (1996) The effect of docosahexaenoic acid on the electroretinogram of the guinea pig Lipids 31,65-70
[CrossRef] [PubMed]Weisinger, HS, Vingrys, AJ, Abedin, L, Sinclair, AJ. (1998) Effect of diet on the rate of depletion of n-3 fatty acids in the retina of the guinea pig J Lipid Res 39,1274-1279
[PubMed]Provis, JM. (2001) Development of the primate retinal vasculature Prog Retinal Eye Res 20,799-821
[CrossRef] Carlson, SE, Werkman, SH, Rhodes, PG, Tolley, EA. (1993) Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation Am J Clin Nutr 58,35-42
[PubMed]Hoffman, DR, Birch, EE, Birch, DG, Uauy, RD. (1993) Effects of supplementation with omega 3 long-chain polyunsaturated fatty acids on retinal and cortical development in premature infants Am J Clin Nutr 57,807S-812S
[PubMed]Weisinger, HS, Vingrys, AJ, Sinclair, AJ. (1996) Effect of dietary n-3 deficiency on the electroretinogram in the guinea pig Ann Nutr Metab 40,91-98
[CrossRef] [PubMed]Sarkadi-Nagy, E, Wijendran, V, Diau, G-Y, et al (2003) The influence of prematurity and long chain polyunsaturate supplementation in four-week adjusted age baboon neonate brain and related tissues Pediatr Res 54,244-252
[CrossRef] [PubMed]Su, HM, Bernardo, L, Mirmiran, M, et al (1999) Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons Pediatr Res 45,87-93
[CrossRef] [PubMed] Jensen, RG eds. Handbook of Milk Composition 1995 Academic Press New York.
Breton, ME, Schueller, AW, Lamb, TD, Pugh, EN, Jr (1994) Analysis of ERG a-wave amplification and kinetics in terms of the G-protein cascade of phototransduction Invest Ophthalmol Vis Sci 35,295-309
[PubMed]Carlson, SE, Ford, AJ, Werkman, SH, et al (1996) Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin Pediatr Res 39,882-888
[CrossRef] [PubMed]Uauy, RD, Birch, DG, Birch, EE, et al (1990) Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates Pediatr Res 28,485-492
[CrossRef] [PubMed]Carlson, SE, Werkman, SH, Tolley, EA. (1996) Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia Am J Clin Nutr 63,687-697
[PubMed]Sauerwald, TU, Hachey, DL, Jensen, CL, et al (1996) Effect of dietary alpha-linolenic acid intake on incorporation of docosahexaenoic and arachidonic acids into plasma phospholipids of term infants Lipids 31(suppl),S131-S135
[CrossRef] [PubMed]Neuringer, M. (2000) Infant vision and retinal function in studies of dietary long-chain polyunsaturated fatty acids: methods, results, and implications Am J Clin Nutr 71,256S-267S
[PubMed]Karwoski, C. (1991) Introduction to the origins of electroretinographic components Heckenlively, JR Arden, GB eds. Principles and Practice of Clinical Electrophysiology of Vision ,87-90 Mosby St. Louis.
Litman, BJ, Niu, SL, Polozova, A, Mitchell, DC. (2001) The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction J Mol Neurosci 16,237-242discussion 279–284
[CrossRef] [PubMed]Feller, SE, Gawrisch, K, Woolf, TB. (2003) Rhodopsin exhibits a preference for solvation by polyunsaturated docosahexaenoic acid J Am Chem Soc 125,4434-4435
[CrossRef] [PubMed]Eldho, NV, Feller, SE, Tristram-Nagle, S, et al (2003) Polyunsaturated docosahexaenoic vs docosapentaenoic acid-differences in lipid matrix properties from the loss of one double bond J Am Chem Soc 125,6409-6421
[CrossRef] [PubMed]Leaf, AA, Green, CR, Esack, A, et al (1995) Maturation of electroretinograms and visual evoked potentials in preterm infants Dev Med Child Neurol 37,814-826
[PubMed]Ntambi, JM. (1992) Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver J Biol Chem 267,10925-10930
[PubMed]Hendrickson, A. (1992) A morphological comparison of foveal development in man and monkey Eye 6,136-144
[CrossRef] [PubMed]Su, HM, Keswick, LA, Brenna, JT. (1996) Increasing dietary linoleic acid in young rats increases and then decreases docosahexaenoic acid in retina but not in brain Lipids 31,1289-1298
[CrossRef] [PubMed]